Comparison of therapeutic effects of topical Isotretinoin %0.05 and Clindamycine %1 in the treatment of acne vulgaris
- Conditions
- mild to moderate acne vulgaris.Acne vulgaris
- Registration Number
- IRCT201105032581N2
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
patients with mild to moderate acne between 11 to 30 years old; patients who have at most 20 inflammatory lesion (papule, pustule) in one side of face and don't have more than 3 nodule or cyst in the same side; tendency to intend in study. Exclusion criteria: pregnant and lactating women; patients who have used topical anti acne drugs in the recent month; patients who have used oral anti acne drugs in past 2 months; having any other facial skin disease other than acne; having sever nodulocystic acne; consumption of acne inducing drugs such as lithium, oral steroid, vit B12, brom and iodide drugs; patients who have more than 20 inflammatory lesion (papule, pustule) in one side of face and have more than 3 nodule or cyst in the same side.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity. Timepoint: every 30 days. Method of measurement: History and clinical examination.
- Secondary Outcome Measures
Name Time Method Pustules. Timepoint: every 30 days. Method of measurement: clinical examination.;Total acne lesions. Timepoint: every 30 days. Method of measurement: clinical examination.;Index of acne severity. Timepoint: every 30 days. Method of measurement: clinical examination, statistical measurment.;Patient satisfaction. Timepoint: every 30 days. Method of measurement: Questionnare.;Comedones. Timepoint: every 30 days. Method of measurement: clinical examination.